Every SEC Form 3/4/5 on record for this filer (CIK 1859226) — 2 issuers, 12 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PODD | INSULET CORP | Director | 2021-10-18 → 2026-06-04 | 13 | −$568,870 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | Director · lapsed | 2021-04-30 → 2023-03-09 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PODD | 2026-06-03 | Sell | 418 | $143.27 | $59,887 | 4,329 |
| PODD | 2025-06-09 | Sell | 481 | $305.73 | $147,056 | 3,087 |
| PODD | 2024-11-12 | Sell | 508 | $274.80 | $139,598 | 2,790 |
| PODD | 2024-06-04 | Sell | 360 | $182.58 | $65,729 | 3,298 |
| PODD | 2023-12-15 | Sell | 72 | $207.08 | $14,910 | 2,278 |
| PODD | 2023-06-05 | Sell | 500 | $283.38 | $141,690 | 2,350 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
